Skip to main content

Advertisement

Log in

“Can we try to avoid surgery first?”—Real-world experience with surgery for Peyronie’s disease in the post-intralesional collagenase setting

  • Correspondence
  • Published:
International Journal of Impotence Research Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zhang F, Xiong Y, Wang W, Wu C, Qin F, Yuan J. The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: a meta-analysis of published prospective studies. Front Pharmacol. 2022;13:973394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li MK, Sigalos JT, Yoffe DA, Modiri N, Hu MY, Gaither TW, et al. Multiple courses of intralesional collagenase injections for Peyronie disease: a retrospective analysis. J Sex Med. 2023;20:200–4.

    Article  PubMed  Google Scholar 

  3. Levine LA, Larsen SM. Surgical correction of persistent Peyronie’s disease following collagenase Clostridium histolyticum treatment. J Sex Med. 2015;12:259–64.

    Article  PubMed  Google Scholar 

  4. Cocci A, Ralph D, Djinovic R, Hatzichristodoulou G, Morelli G, Salonia A, et al. Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study. Sci Rep. 2021;11:166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wymer K, Kohler T, Trost L. Comparative cost-effectiveness of surgery, collagenase clostridium histolyticum, and penile traction therapy in men with Peyronie’s disease in an era of effective clinical treatment. J Sex Med. 2019;16:1421–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: RK, JNM, and SVE; Data curation: RK and KVR; Formal analysis: RK, JNM, and SVE; Investigation: RK, KVR, JNM, and SVE; Project administration: RK, KVR, JNM, and SVE; Supervision: JNM and SVE; Visualization: RK and SVE; Writing – original draft: RK, KVR, JNM, and SVE. Writing – review & editing: RK, KVR, JNM, and SVE.

Corresponding author

Correspondence to Sriram V. Eleswarapu.

Ethics declarations

Competing interests

JNM serves as a consultant to Boston Scientific Corporation, Endo Pharmaceuticals, and Halozyme Therapeutics and receives compensation. KVR serves as a speaker for Boston Scientific Corporation and Halozyme Therapeutics and receives compensation. RK and SVE declare no potential conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kianian, R., Regets, K.V., Mills, J.N. et al. “Can we try to avoid surgery first?”—Real-world experience with surgery for Peyronie’s disease in the post-intralesional collagenase setting. Int J Impot Res 36, 171–172 (2024). https://doi.org/10.1038/s41443-023-00713-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-023-00713-5

  • Springer Nature Limited

This article is cited by

Navigation